Medium-term Management Plan
16-18 Mid-term Management Plan Break Through to Tomorrow
To further realize our principles, the Alfresa Group has formulated "16-18 Mid-term Management Plan Break Through to Tomorrow" with "Strengthen business foundation with one Alfresa initiatives," "Expand the health and medical-related fields," and "Reform business model ahead of changes in the business environment" as Group management policies called "Challenge 3."
Group Management Policies
- Strengthen Business Foundation with One Alfresa Initiatives
- Expand the Health and Medical-related Fields
- Reform Business Model Ahead of Changes in the Business Environment
➊Strengthen Business Foundation with One Alfresa Initiatives
We will work to spread the Alfresa Group brand through comprehensive approaches to medical institutions, dispensing pharmacies, manufacturers and others by bringing together the Group's strengths in each business segment and generating synergy.
➋Expand the Health and Medical-related Fields
We will invest management resources mainly in the health and medical-related fields to strengthen the Alfresa Group's distinctive business model centered on the ethical pharmaceuticals supply chain.
➌Reform Business Model Ahead of Changes in the Business Environment
We will promote reforms in each business segment ahead of changes in the business environment, and advance efforts toward strengthening profit foundations and expanding business. Additionally, we will leverage the know-how acquired with the strong business model in Japan to advance business expansion overseas, centered on Asia.
|Ethical Pharmaceuticals Wholesaling Business||
|Self-medication Products Wholesaling Business||
Group Management Targets
|Net Sales||2.7 trillion yen|
|Operating Income Margin||1.5% +|
|Net Profit Margin*||1.2% +|
- Net profit margin attributable to owners of parent company
|Investment(cumulative total in 16-18 plan)||About 100 billion yen level|
|Shareholder Return Policy||DOE* 2.0％ +|
- DOE : Dividend on Equity